Evidence map›Paper›PMID 40489296›Full record

ReviewClinical advances in periodontics2025

Risk for peri-implant diseases and defects: Report of workgroup 1 of the joint AO/AAP consensus conference on prevention and management of peri-implant diseases.

Purnima S Kumar, Joseph Kan, Maria Elisa Galarraga-Vinueza, Guo-Hao Lin, Alberto Monje, Lorenzo Tavelli, Sandra Stuhr, Yung-Ting Hsu, Junying Li, Alexandra Tsigarida and 4 more

Abstract readConsensus StatementReview
In one paragraph

Review in Clinical advances in periodontics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Purnima S KumarSchool of Dentistry, University of Michigan, Ann Arbor, Michigan, USA.
Joseph KanSchool of Dentistry, Loma Linda University, San Bernadino, California, USA.
Maria Elisa Galarraga-VinuezaSchool of Dentistry, Tufts University, Boston, Massachusetts, USA.
Guo-Hao LinUniversity of California San Francisco School of Dentistry, San Francisco, California, USA.
Alberto MonjeUniversity Internacional de Catalunya, Barcelona, Spain.
Lorenzo TavelliHarvard University School of Dental Medicine, Boston, Massachusetts, USA.
Sandra StuhrSchool of Dentistry, University of Michigan, Ann Arbor, Michigan, USA.
Yung-Ting HsuSchool of Dentistry, University of Washington, Seattle, Washington, USA.
Junying LiSchool of Dentistry, University of Michigan, Ann Arbor, Michigan, USA.
Alexandra TsigaridaUniversity of Rochester, Rochester, New York, USA.
Debora DiasSchool of Dental Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
SukirthMurthy GanesanSchool of Dentistry, University of Iowa, Iowa City, Iowa, USA.
Shi YinPrivate Practice, Seattle, Washington, USA.
Don CurtisUniversity of California San Francisco School of Dentistry, San Francisco, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA consensus meeting on peri-implant diseases and treatment was initiated by the American Academy of Periodontology (AAP) and the Academy of Osseointegration (AO) with the goal of developing subject- and site-level risk profiles for peri-implant diseases and defects, and risk-informed treatment recommendations. This report summarizes the conclusions of Working Group 1.

methodsWorking Group 1 evaluated the risk for peri-implant diseases and defects based on four commissioned systematic reviews, followed by an in-person workshop to discuss the reviews and the inferences.

resultsSeveral factors emerged as risk markers for peri-implant mucositis, peri-implantitis, as well as for soft and hard tissue discrepancies and defects in the absence of disease.

conclusionPatient- and site-level factors can increase the odds of developing peri-implant disease or defects in soft tissue and marginal bone surrounding clinically healthy implants. Risk-informed treatment recommendations were made by the panel of experts. KEY POINTS: This consensus estimates risk based on both patient and site-level factors. Consideration must be given to modifiable and non-modifiable risk factors, and treatment modified accordingly. There is a lack of primary research on several topics that were considered by the consensus panel, and several gaps in knowledge still continue to exist.

Indexed as

Dental ImplantsPeri-ImplantitisHumansRisk AssessmentRisk FactorsStomatitisDental Implantsboneconsensusperi‐implant diseasesperi‐implantitisperi‐implant mucositisrisksoft‐tissue

Identifiers

PMID40489296
PMCPMC12266310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.